Categories: NewsPersonal Data

Conference call interim report

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

GOTHENBURG, Sweden, July 3, 2024 /PRNewswire/ — Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q2, 2024. The presentation will be held in English.

Time: Wednesday 17 July, 2024 at 10.00 a.m. CET.

To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy | Vitrolife Group

Register for the call here

Vitrolife Group participants:
Bronwyn Brophy O´Connor, CEO
Patrik Tolf, CFO

The press release for the interim report will be released at 8.00 CET on the same day.

Before the conference call, presentation material will be available at the company web page.

A recorded version of the telephone conference will be available for seven days on number +44 (0) 20 3451 9993 (International), access code 7692641#.

Gothenburg, 3 July 2024
VITROLIFE AB (publ)

Contact: 
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/vitrolife-ab–publ-/r/conference-call-interim-report,c4010494

The following files are available for download:

 

View original content:https://www.prnewswire.com/news-releases/conference-call-interim-report-302188898.html

SOURCE Vitrolife AB (publ)

Staff

Recent Posts

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)…

1 hour ago

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology…

1 hour ago

Entourage Health Corp. Announces Closing of Plan of Arrangement

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:…

1 hour ago

Tr1X Awarded $8 Million CIRM Grant to Support TRX103 Phase 1/2a Clinical Trial for Graft-Versus-Host Disease

SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical…

1 hour ago

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee

Highly experienced biotech executive and board member will assist Kalaris in achieving its next phase…

1 hour ago

AIM Congress 2025 Kicks Off in Abu Dhabi on Monday with 20,000 Participants

 Al Zeyoudi: "Hosting such major international events reflects the UAE's pivotal role as a global…

4 hours ago